What are the IRLSSG recommendations for the long-term treatment of restless legs syndrome (RLS)?

Updated: Feb 22, 2017
  • Author: Ali M Bozorg, MD; Chief Editor: Selim R Benbadis, MD  more...
  • Print

The 2013 IRLSSG guidelines for the long-term treatment of RLS recommends either a dopamine-receptor agonist or an alpha2-delta calcium-channel ligand as first-line treatment therapy for RLS in most patients, with the choice of medication depending on symptom severity, cognitive status, history, and comorbid conditions. [37]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!